XML 83 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 40.9 $ 0
Trading securities 20.0 16.6
Foreign exchange derivative assets 18.2 6.4
Total assets at recurring fair value measurement 1,833.9 1,536.4
Foreign exchange derivative liabilities 1.5 58.5
Total liabilities at recurring fair value measurement 2,333.6 2,041.9
Purchased cash convertible note hedge
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,650.3 1,303.0
Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative liabilities 0 15.8
Cash conversion feature of Cash Convertible Notes
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,650.3 1,303.0
Contingent consideration
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 681.8 664.6
Money market funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 40.9 0
Equity securities — exchange traded funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 20.0 16.6
Available-for-sale fixed income investments
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 27.7 26.8
U.S. Treasuries
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 13.1 12.8
Corporate bonds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 11.7 10.7
Agency mortgage-backed securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.6 0.7
Other
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 2.3 2.6
Total available-for-sale equity securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.2 0.2
Biosciences industry
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.2 0.2
Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative assets 76.6 183.4
Level 1
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 40.9 0
Trading securities 20.0 16.6
Total assets at recurring fair value measurement 61.1 16.8
Level 1 | Money market funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 40.9 0
Level 1 | Equity securities — exchange traded funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 20.0 16.6
Level 1 | Total available-for-sale equity securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.2 0.2
Level 1 | Biosciences industry
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.2 0.2
Level 2
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign exchange derivative assets 18.2 6.4
Total assets at recurring fair value measurement 1,772.8 1,519.6
Foreign exchange derivative liabilities 1.5 58.5
Total liabilities at recurring fair value measurement 1,651.8 1,377.3
Level 2 | Purchased cash convertible note hedge
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,650.3 1,303.0
Level 2 | Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative liabilities 0 15.8
Level 2 | Cash conversion feature of Cash Convertible Notes
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,650.3 1,303.0
Level 2 | Available-for-sale fixed income investments
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 27.7 26.8
Level 2 | U.S. Treasuries
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 13.1 12.8
Level 2 | Corporate bonds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 11.7 10.7
Level 2 | Agency mortgage-backed securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.6 0.7
Level 2 | Other
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 2.3 2.6
Level 2 | Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative assets 76.6 183.4
Level 3
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities at recurring fair value measurement 681.8 664.6
Level 3 | Contingent consideration
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration $ 681.8 $ 664.6